Analysed MANGOCEUTICALS INC (MGRX:NASDAQ) News Sources
Mangoceuticals Announces Lawsuit Seeking Damages Exceeding $73 Million Against Former Technology Consulting and Software Development Firm, Clarity Ventures, Inc.
17-03-2026
yahoo.com
Mangoceuticals, Inc. Announces PCT Patent Filing for MGX-0024 Antiviral Technology to Include Inhibiting Respiratory or Orally Acquired Virus Infection in Animals or Birds
06-03-2026
yahoo.com
Mangoceuticals’ Patented MGX-0024 Achieves Zero Respiratory-Related Mortality in 29,000-Bird Field Trials and Demonstrates Prophylactic Benefit Against H5N1 in Controlled Government Study
23-02-2026
yahoo.com
MangoRx Experiences Initial Success with Newly Launched $99/month All-Inclusive Injectable Testosterone Replacement Therapy (TRT) Treatment Program
19-02-2026
yahoo.com
Mangoceuticals, Inc. Announces Closing of $2.5 Million Registered Direct and Private Placements
19-12-2025
yahoo.com
Mangoceuticals, Inc. Announces $2.5 Million Registered Direct and Private Placements Priced at the Market Under Nasdaq Rules
18-12-2025
yahoo.com
Eli Lilly and Novo Nordisk disown Mangoceuticals’ GLP-1RA partnership claim
14-11-2025
pharmaceutical-technology.com
What is the current price of MANGOCEUTICALS INC (MGRX:NASDAQ)?
The current price of MANGOCEUTICALS INC (MGRX:NASDAQ) is $0.4731.
MANGOCEUTICALS INC (MGRX:NASDAQ) absolute price change since previous trading day?
The absolute price change of MANGOCEUTICALS INC (MGRX:NASDAQ) since the previous trading day is $0.0691.
MANGOCEUTICALS INC (MGRX:NASDAQ) percentage price change since previous trading day?
The percentage price change of MANGOCEUTICALS INC (MGRX:NASDAQ) since the previous trading day is 17.104%.
What is the most recent average sentiment score for MANGOCEUTICALS INC (MGRX:NASDAQ)?
The most recent average sentiment score for MANGOCEUTICALS INC (MGRX:NASDAQ) is 61 out of 100.
What is the most recent average sentiment for MANGOCEUTICALS INC (MGRX:NASDAQ)?
The most recent sentiment for MANGOCEUTICALS INC (MGRX:NASDAQ) is .
SEC-8K** Filing Available For MANGOCEUTICALS INC (MGRX:NASDAQ)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.